BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29085505)

  • 1. Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma.
    Proungvitaya S; Sombattheera S; Boonsiri P; Limpaiboon T; Wongkham S; Wongkham C; Titapun A; Proungvitaya T
    Oncol Lett; 2017 Oct; 14(4):4943-4948. PubMed ID: 29085505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of glycocholic acid and taurochenodeoxycholic acid as phenotypic biomarkers in cholangiocarcinoma.
    Song WS; Park HM; Ha JM; Shin SG; Park HG; Kim J; Zhang T; Ahn DH; Kim SM; Yang YH; Jeong JH; Theberge AB; Kim BG; Lee JK; Kim YG
    Sci Rep; 2018 Jul; 8(1):11088. PubMed ID: 30038332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cathepsin B to cystatin C ratio as a potential marker for the diagnosis of cholangiocarcinoma.
    Monsouvanh A; Proungvitaya T; Limpaiboon T; Wongkham C; Wongkham S; Luvira V; Proungvitaya S
    Asian Pac J Cancer Prev; 2014; 15(21):9511-5. PubMed ID: 25422248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total serum bile acid as a potential marker for the diagnosis of cholangiocarcinoma without jaundice.
    Sombattheera S; Proungvitaya T; Limpaiboon T; Wongkham S; Wongkham C; Luvira V; Proungvitaya S
    Asian Pac J Cancer Prev; 2015; 16(4):1367-70. PubMed ID: 25743800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls.
    Zhang X; Yang Z; Shi Z; Zhu Z; Li C; Du Z; Zhang Y; Wang Z; Jiao Z; Tian X; Zhang J; Zhai W; Kan Q
    J Steroid Biochem Mol Biol; 2021 Jan; 205():105775. PubMed ID: 33130021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Resolvin D1 in the Differential Diagnosis of the Cholangiocarcinoma and Benign Biliary Diseases.
    Gül-Utku Ö; Karatay E; Ergül B; Kisa Ü; Erdin Z; Oğuz D
    Clin Lab; 2020 May; 66(5):. PubMed ID: 32390401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma.
    Chanakankun R; Proungvitaya T; Chua-On D; Limpaiboon T; Roytrakul S; Jusakul A; Titapun A; Jarearnrat A; Proungvitaya S
    Oncol Lett; 2020 Jan; 19(1):930-942. PubMed ID: 31897206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma.
    Wintachai P; Lim JQ; Techasen A; Lert-Itthiporn W; Kongpetch S; Loilome W; Chindaprasirt J; Titapun A; Namwat N; Khuntikeo N; Jusakul A
    Diagnostics (Basel); 2021 May; 11(6):. PubMed ID: 34070951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum adhesion molecule-1 (ICAM-1) as a potential prognostic marker for cholangiocarcinoma patients.
    Janan M; Proungvitaya S; Limpaiboon T; Proungvitaya T; Roytrakul S; Wongkham C; Jearanaikoon P; Chur-in S; Wongkham S
    Asian Pac J Cancer Prev; 2012; 13 Suppl():107-14. PubMed ID: 23480771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma hydroxyproline, MMP-7 and collagen I as novel predictive risk markers of hepatobiliary disease-associated cholangiocarcinoma.
    Prakobwong S; Charoensuk L; Hiraku Y; Pinlaor P; Pairojkul C; Mairiang E; Sithithaworn P; Yongvanit P; Khuntikeo N; Pinlaor S
    Int J Cancer; 2012 Aug; 131(4):E416-24. PubMed ID: 21935919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma.
    Sanmai S; Proungvitaya T; Limpaiboon T; Chua-On D; Seubwai W; Roytrakul S; Wongkham S; Wongkham C; Somintara O; Sangkhamanon S; Proungvitaya S
    Oncol Lett; 2019 Jun; 17(6):5275-5282. PubMed ID: 31186744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum α1β-glycoprotein and afamin ratio as potential diagnostic and prognostic markers in cholangiocarcinoma.
    Tolek A; Wongkham C; Proungvitaya S; Silsirivanit A; Roytrakul S; Khuntikeo N; Wongkham S
    Exp Biol Med (Maywood); 2012 Oct; 237(10):1142-9. PubMed ID: 23104505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of bile and serum mucin5AC in cholangiocarcinoma: diagnostic performance and biologic significance.
    Danese E; Ruzzenente O; Ruzzenente A; Iacono C; Bertuzzo F; Gelati M; Conci S; Bendinelli S; Bonizzato G; Guglielmi A; Salvagno GL; Lippi G; Guidi GC
    Surgery; 2014 Nov; 156(5):1218-24. PubMed ID: 25151557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma.
    Voigtländer T; Metzger J; Husi H; Kirstein MM; Pejchinovski M; Latosinska A; Frantzi M; Mullen W; Book T; Mischak H; Manns MP
    J Biomed Sci; 2020 Jan; 27(1):13. PubMed ID: 31900160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State of serum markers for detection of cholangiocarcinoma.
    Wongkham S; Silsirivanit A
    Asian Pac J Cancer Prev; 2012; 13 Suppl():17-27. PubMed ID: 23480761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level as a Potential Biomarker of Cholangiocarcinoma.
    Tummanatsakun D; Proungvitaya T; Roytrakul S; Limpaiboon T; Wongkham S; Wongkham C; Silsirivanit A; Somintara O; Sangkhamanon S; Proungvitaya S
    Biomolecules; 2019 Aug; 9(9):. PubMed ID: 31454981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
    Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of biliary bile acids in patients with benign biliary diseases, hepatocellular carcinoma and cholangiocarcinoma.
    Jusakul A; Khuntikeo N; Haigh WG; Kuver R; Ioannou GN; Loilome W; Namwat N; Bhudhisawasdi V; Pugkhem A; Pairojkul C; Yongvanit P
    Asian Pac J Cancer Prev; 2012; 13 Suppl():77-82. PubMed ID: 23480749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum and bile biomarkers for cholangiocarcinoma.
    Alvaro D
    Curr Opin Gastroenterol; 2009 May; 25(3):279-84. PubMed ID: 19396965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of CCDC25 in cholangiocarcinoma tissue samples.
    Proungvitaya S; Klinthong W; Proungvitaya T; Limpaiboon T; Jearanaikoon P; Roytrakul S; Wongkham C; Nimboriboonporn A; Wongkham S
    Oncol Lett; 2017 Aug; 14(2):2566-2572. PubMed ID: 28789463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.